In a recent study, HK2 was identified as upregulated under inflammatory conditions in mice and humans irrespective of disease subtype (CD, UC, or non-IBD colitis) and suppressing HK2 expression even protected from experimental colitis [6] placing HK2 as a potential disease marker. Here, HK2 is linked to inflammatory bowel disease.